Business Segments Biosynex OTC Markets
Stocks
BSYXF
FR0011005933
Medical Equipment, Supplies & Distribution
|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 09-04 | Biosynex: creditors to vote on financial safeguard plan |  |
| 08-06 | Biosynex hit by cyberattack, operational activity remains intact | |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Sale of Merchandise | 175M | 99.36M | 52.09M | 42.94M | 39.47M | |||||
| - | - | - | - | 528K | ||||||
Products Sold | 44.06M | 29.86M | 15.39M | 24.63M | 25.21M | |||||
| - | - | - | - | 1.52M | ||||||
Services Sold | 18.58M | 9.39M | 2.37M | 1.89M | 1.52M | |||||
| - | - | - | - | 39.47M | ||||||
Unallocated Immobilised Production | 525K | 672K | 1.35M | 911K | 528K | |||||
Unallocated Operating Grants | 436K | 282K | - | - | - | |||||
| - | - | - | - | 25.21M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
France | 194M | 120M | 52.5M | 52.82M | 49.26M | |||||
| - | - | - | - | 45.93M | ||||||
Export | 189M | 76.4M | 40.4M | 48.35M | 45.93M | |||||
Unallocated Operating Subsidies | - | - | - | - | - | |||||
Unallocated Fixed Production | - | - | - | - | - | |||||
| - | - | - | - | 49.26M |
- Stock Market
- Stocks
- ALBIO Stock
- BSYXF Stock
- Financials Biosynex
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
